Bing

SEARCH HISTORY

Your own personalized stock watchlist! It's a 100% FREE Motley Fool service ... What: Shares of small-cap biotech Delcath Systems (Nasdaq: DCTH ) popped more than 10% in intraday trading, as takeover rumors may have sparked investor excitement.
The Motley Fool · 10/7/2010
NEW YORK, Feb. 10, 2015 /PRNewswire/ -- Delcath Systems, Inc. DCTH, +3.64% today announced its intention to offer, subject to market and other conditions, shares of its common stock and warrants to purchase shares of common stock in an …
Market Watch · 2/10/2015
Plug Power Inc. (PLUG)’s monthly performance stand at 6.25% with a profit margin of -35.10% and has an analyst rating of 2.3 (Click To Expand Current Stock Data:) NetApp, Inc. (NTAP) of the Technology sector (Data Storage Devices) is down -0.27% …
wallstreetscope.com · 6/1/2015
Eamonn P. Hobbs, Chief Executive Officer, President and Director of Delcath Systems, Inc. (DCTH) will visit NASDAQ MarketSite in Times Square and preside over the NASDAQ Opening Bell. The Opening Bell is available from 9:20 a.m. to 9:35 a.m. on …
GlobeNewswire · 5/13/2010
Delcath Systems, Inc. (NASDAQ: DCTH) fell 24.24% to $1.00 after the company priced $2.8 million public offering of common stock and warrants. Jive Software, Inc. (NASDAQ: JIVE) tumbled 13.63% to $5.26. Jive reported a Q4 loss of $0.17 per share on …
Benzinga · ByLisa Levin · 2/11/2015
NEW YORK, July 16, 2015 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical ... each unit consisting of one share of its common stock, 0.75 of one Series A Warrant to purchase one share of its common …
The Business Journal · 7/16/2015
NEW YORK, Jan. 12 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH) announced today that it will present at the 12th Annual Needham Growth Stock Conference at the New York Palace Hotel. The Company's presentation is scheduled for …
redOrbit · 1/12/2010
Wealth Daily is launching our first-ever stock picking contest. It's an opportunity to square ... Back on April 19, I wrote about Delcath Systems (NASDAQ: DCTH). The firm, which has a promising liver cancer treatment system, is up 56% since.
Wealth Daily · 5/3/2010
He recommended buying this stock. Seabridge Gold : “If that’s the way you want ... Delcath Systems : Cramer likes DCTH as a speculative biotech play. Linn Energy : Linn right now has too much natural-gas exposure, Cramer said. Investors should …
CNBC · 5/25/2010